Thursday, December 28, 2006

Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer

Lapatinib plus capecitabine is superior to capecitabine alone in women with HER2-positive advanced breast cancer that has progressed after treatment with regimens that included an anthracycline, a taxane, and trastuzumab. --Click the title of this post to read the full article from its source--

Labels: , , , , ,

/* WebRing Code */